| 00:00:00 | EMBRYONIC STEM CELLS AND I WOULD LIKE TO EXPLAIN WHY. |
| 00:00:05 | BECAUSE THE NATIONAL INSTITUTE OF HEALTH STUDY EXAMINED THE POTENTIAL OF ADULT AND EMBRYONIC STEM CELLS FOR CURING DISEASE AND THEY FOUND THAT THE EMBASSY RONIC STEM CELLS HAVE IMPORTANT ADVANTAGES OVER ADULT SYSTEM CELLS. |
| 00:00:23 | THE EMBASSY BROUGHTIC -- EMBRYO ONIC CAN POTENTIALLY REPLACE ANY CELL IN THE HUMAN BODY. |
| 00:00:34 | ADULTS, HOWEVER, ARE NOT AS FLEXIBLE AS EMBRYONIC ONCE AND THEY CAN'T DEAF INTO MANY DIFFERENT TYPES OF CELLS. |
| 00:00:46 | THEY CANNOT BE DUPLICATED -- I YIELD MYSELF ANOTHER MINUTE. |
| 00:00:51 | THEY CANNOT BE DUPE INDICATED IN THE SAME QUANTITIES IN THE LABORATORY OF THE THEY ARE DANGEROUS AND DIFFICULT TO EXTRACT FROM AN ADULT PATIENT. |
| 00:01:02 | FOR INSTANCE, OBTAINING ADULT BRAIN STEM CELLS COULD REQUIRE LIFE-THREATENING SURGERY. |
| 00:01:08 | SO THE N. |
| 00:01:09 | I.H. FOUND IN A STUDY THAT THERAPYIC CLONING WOULD ALLOWS -- THERAPEUTIC CLONING TO ALLOW US TO CREATE TREATMENTS THAT WOULD NOT BE OBJECTED BY THE PATIENT IMMUNE SYSTEM BECAUSE IT HAS THE SAME D. |
| 00:01:29 | N.A. FOR WHATEVER IT MAY BE WORTH I REFER THIS STUDY TO MY GOOD FRIEND, THE CHAIRMAN. |
| 00:01:35 | AND I WOULD YIELD -- I'LL RESERVE SERVE AM. |
| 00:01:41 | THE SPEAKER PRO TEMPORE: THE GENTLEMAN FROM WISCONSIN. |
| 00:01:44 | MR. |
| 00:01:45 | SENSENBRENNER: I YIELD MYSELF A MINUTE TO CLARIFY THE RECORD. |
| 00:01:48 | I'M SURE THE STUDY CITED BY THE GENTLEMAN FROM MICHIGAN IS A VALUABLE ONE. |
| 00:01:52 | THE FACT IS IT'S NOT ON POINT TO THIS DEBATE. |
| 00:01:55 | THIS BILL DOES NOT PREVENT RESEARCH ON EMBRYONIC |
Mr. CONYERS. Mr. Speaker, I yield myself 2 minutes.
I rise to merely point out to the distinguished chairman of the Committee on the Judiciary, the gentleman from Wisconsin (Mr. SENSENBRENNER), that he may be over-reliant on adult stem cells as a viable alternative to embryonic stem cells, and I would like to explain why.
A National Institute of Health study examined the potential of adult and embryonic stem cells for curing disease, and they found that the embryonic stem cells have important advantages over adult stem cells. The embryonic stem cells can develop into many more different types of cells. They can potentially replace any cell in the human body. Adult stem cells, however, are not as flexible as embryonic ones. They cannot develop into many different types of cells. They cannot be duplicated in the same quantities in the laboratory. They are difficult and dangerous sometimes to extract from an adult patient. For instance, obtaining adult brain stem cells could require life-threatening surgery.
So the NIH found in its study that therapeutic cloning would allow us to create stem cell medical treatments that would not be rejected by the patient's immune system, because they have the patient's own DNA.
So for whatever it may be worth, I refer this study to my good friend, the chairman.
Mr. Speaker, I reserve the balance of my time.